Piper Sandler says Alzheimer’s treatment Leqembi will help drive the stock up 20% in coming months. Leqembi is currently awaiting full approval from the FDA.
You are here: Home / Piper Sandler says this biotech stock can outperform thanks to Alzheimer’s treatment